These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dopaminergic dsyfunction in Tourette syndrome. Singer HS; Butler IJ; Tune LE; Seifert WE; Coyle JT Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010 [TBL] [Abstract][Full Text] [Related]
4. Treating Tourette syndrome with haloperidol: predictors of success. Schwabe MJ; Konkol RJ Wis Med J; 1989 Oct; 88(10):23-7. PubMed ID: 2815810 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of Gilles de la Tourette Syndrome with haloperidol and clonidine]. Fennig S; Bauer A; Kronnenberg Y Harefuah; 1984 May; 106(10):457-8. PubMed ID: 6590432 [No Abstract] [Full Text] [Related]
8. Behavioral effects of haloperidol in young Tourette syndrome patients. Bogomolny A; Erenberg G; Rothner AD Adv Neurol; 1982; 35():427-32. PubMed ID: 6959520 [No Abstract] [Full Text] [Related]
9. Tourette syndrome in children: ethnic and genetic factors and response to stimulant drugs. Golden GS Adv Neurol; 1982; 35():287-9. PubMed ID: 6959502 [No Abstract] [Full Text] [Related]
10. Amantadine in Tourette syndrome. Borison RL; Davis JM Curr Psychiatr Ther; 1983; 22():127-30. PubMed ID: 6587960 [No Abstract] [Full Text] [Related]
11. Clinical efficacy of haloperidol, pimozide, penfluridol, and clonidine in the treatment of tourette syndrome. Shapiro AK; Shapiro E Adv Neurol; 1982; 35():383-6. PubMed ID: 6959514 [No Abstract] [Full Text] [Related]
12. [Tourette syndrome. New aspects on pharmacological treatment]. Aabech HS Tidsskr Nor Laegeforen; 1989 Mar; 109(9):961-3. PubMed ID: 2565050 [TBL] [Abstract][Full Text] [Related]
13. Overview of pharmacological approaches to therapy for Tourette syndrome. van Woert MH; Rosenbaum D; Enna SJ Adv Neurol; 1982; 35():369-75. PubMed ID: 6183950 [No Abstract] [Full Text] [Related]
14. Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research. Leckman JF; Cohen DJ Psychiatr Dev; 1983; 1(3):301-16. PubMed ID: 6324164 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Gilles de la Tourette syndrome with depot neuroleptics. Paolucci S; Buttinelli C; Fiume S; Ciani S; Lenzi GL Acta Neurol (Napoli); 1984 Jun; 6(3):222-4. PubMed ID: 6591768 [No Abstract] [Full Text] [Related]
16. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome]. Takano K; Ishiguro T Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527 [TBL] [Abstract][Full Text] [Related]
17. Tics of Tourette: important points in management. Daniel AE; Chapel JL J Dev Behav Pediatr; 1981 Dec; 2(4):166-7. PubMed ID: 6947982 [No Abstract] [Full Text] [Related]
18. New pharmacological approaches in the treatment of Tourette syndrome. Borison RL; Ang L; Chang S; Dysken M; Comaty JE; Davis JM Adv Neurol; 1982; 35():377-82. PubMed ID: 6756088 [No Abstract] [Full Text] [Related]
19. [Gilles de la Tourette's syndrome (Maladia des tics)--successful treatment with haloperidol]. Nishiura N; Hirota Y No To Shinkei; 1970 Aug; 22(8):931-6. PubMed ID: 5270859 [No Abstract] [Full Text] [Related]